{"disease":{"id":"brca1-hereditary-breast-and-ovarian-cancer-syndrome","name":"brca1 hereditary breast and ovarian cancer syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04494945","title":"Identifying and Caring for Individuals With Inherited Cancer Syndrome","phase":"NA","overall_status":"RECRUITING","enrollment_count":27500,"lead_sponsor_name":"OHSU Knight Cancer Institute","has_results":false},{"nct_id":"NCT02760849","title":"Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":374,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT07381985","title":"Strategy for Management of Patients With Hereditary Cancer Syndromes (HCS) in a Rural Environment","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":200,"lead_sponsor_name":"University of Vermont Medical Center","has_results":false},{"nct_id":"NCT02978495","title":"Neoadjuvant Carboplatin in Triple Negative Breast Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":154,"lead_sponsor_name":"Barretos Cancer Hospital","has_results":false},{"nct_id":"NCT06534424","title":"Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"Ohio State University Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT00892736","title":"Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":98,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}